First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals

Background and Objectives: Multidrug resistance and in particular, carbapenem resistant Gram-negative bacteria is spreading worldwide at an alarming rate. Among the clinically significant carbapenemases, the New Delhi Metallo-β-lactamase (NDM) is one of the most formidable. NDM efficiently hydrolyse...

Full description

Bibliographic Details
Main Authors: Sarah Jehad Ismail, Suhad Saad Mahmoud
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-05-01
Series:Iranian Journal of Microbiology
Subjects:
Online Access:https://ijm.tums.ac.ir/index.php/ijm/article/view/1642
_version_ 1798027131881521152
author Sarah Jehad Ismail
Suhad Saad Mahmoud
author_facet Sarah Jehad Ismail
Suhad Saad Mahmoud
author_sort Sarah Jehad Ismail
collection DOAJ
description Background and Objectives: Multidrug resistance and in particular, carbapenem resistant Gram-negative bacteria is spreading worldwide at an alarming rate. Among the clinically significant carbapenemases, the New Delhi Metallo-β-lactamase (NDM) is one of the most formidable. NDM efficiently hydrolyses β-lactams and is the last-resort among carbapenems. Hence, therapeutic options for NDM producer bacteria become restricted to a handful of antibiotics. The present study was undertaken to detect the prevalence of the blaNDM-variants Metallo β- lactamases (MBLs) among isolates of Pseudomonas aeruginosa recovered from various clinical samples of hospitalized patients in Baghdad, Iraq. Materials and Methods: A total of 100 isolates of Gram-negative bacteria obtained from various clinical samples were subjected to antibiotic susceptibility testing by the disc-diffusion method against meropenem (10 µg), imipenem (10 µg), doripenem (10 µg), polymyxin B (10 µg), colistin (10 µg), amikacin (30 µg), gentamicin (10 µg), aztreonam (30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), ofloxacin (5 µg), cefepime (30 µg), ceftazidime (30 µg), piperacillin-tazobactam (100\10 µg), tigecycline (15 µg) and tetracycline (10 µg). The results were interpreted according to the guidelines suggested by the Clinical Laboratory Standards Institute. Presence of blaNDM was detected by PCR and it was confirmed by DNA sequencing of the gene present in the isolates that exhibited carbapenem resistance. Results: In the present study, four isolates of P. aeruginosa carried the blaNDM, three isolates harboured blaNDM-1 and one isolate harboured blaNDM-2. All isolates were resistant to imipenem and meropenem. The blaNDM-1 carrying isolates remained susceptible to colistin and β-lactamase inhibitors piperacillin-tazobactam. Conclusion: We are reporting emergence of the P. aeruginosa carrying the blaNDM-variant, which exhibited resistance to imipenem and meropenem for the first time in Iraq.
first_indexed 2024-04-11T18:47:34Z
format Article
id doaj.art-9c1efc287342489bbfc1bb62ce70f2b9
institution Directory Open Access Journal
issn 2008-3289
2008-4447
language English
last_indexed 2024-04-11T18:47:34Z
publishDate 2018-05-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Microbiology
spelling doaj.art-9c1efc287342489bbfc1bb62ce70f2b92022-12-22T04:08:42ZengTehran University of Medical SciencesIranian Journal of Microbiology2008-32892008-44472018-05-01102First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitalsSarah Jehad Ismail0Suhad Saad Mahmoud1Department of Biotechnology, University of Baghdad, AL Mansour City, Baghdad, IraqDepartment of Biotechnology, University of Baghdad, AL Mansour City, Baghdad, IraqBackground and Objectives: Multidrug resistance and in particular, carbapenem resistant Gram-negative bacteria is spreading worldwide at an alarming rate. Among the clinically significant carbapenemases, the New Delhi Metallo-β-lactamase (NDM) is one of the most formidable. NDM efficiently hydrolyses β-lactams and is the last-resort among carbapenems. Hence, therapeutic options for NDM producer bacteria become restricted to a handful of antibiotics. The present study was undertaken to detect the prevalence of the blaNDM-variants Metallo β- lactamases (MBLs) among isolates of Pseudomonas aeruginosa recovered from various clinical samples of hospitalized patients in Baghdad, Iraq. Materials and Methods: A total of 100 isolates of Gram-negative bacteria obtained from various clinical samples were subjected to antibiotic susceptibility testing by the disc-diffusion method against meropenem (10 µg), imipenem (10 µg), doripenem (10 µg), polymyxin B (10 µg), colistin (10 µg), amikacin (30 µg), gentamicin (10 µg), aztreonam (30 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), ofloxacin (5 µg), cefepime (30 µg), ceftazidime (30 µg), piperacillin-tazobactam (100\10 µg), tigecycline (15 µg) and tetracycline (10 µg). The results were interpreted according to the guidelines suggested by the Clinical Laboratory Standards Institute. Presence of blaNDM was detected by PCR and it was confirmed by DNA sequencing of the gene present in the isolates that exhibited carbapenem resistance. Results: In the present study, four isolates of P. aeruginosa carried the blaNDM, three isolates harboured blaNDM-1 and one isolate harboured blaNDM-2. All isolates were resistant to imipenem and meropenem. The blaNDM-1 carrying isolates remained susceptible to colistin and β-lactamase inhibitors piperacillin-tazobactam. Conclusion: We are reporting emergence of the P. aeruginosa carrying the blaNDM-variant, which exhibited resistance to imipenem and meropenem for the first time in Iraq.https://ijm.tums.ac.ir/index.php/ijm/article/view/1642P. aeruginosaCarbapenem resistanceblaNDM variants 12
spellingShingle Sarah Jehad Ismail
Suhad Saad Mahmoud
First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
Iranian Journal of Microbiology
P. aeruginosa
Carbapenem resistance
blaNDM variants 1
2
title First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
title_full First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
title_fullStr First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
title_full_unstemmed First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
title_short First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
title_sort first detection of new delhi metallo β lactamases variants ndm 1 ndm 2 among pseudomonas aeruginosa isolated from iraqi hospitals
topic P. aeruginosa
Carbapenem resistance
blaNDM variants 1
2
url https://ijm.tums.ac.ir/index.php/ijm/article/view/1642
work_keys_str_mv AT sarahjehadismail firstdetectionofnewdelhimetalloblactamasesvariantsndm1ndm2amongpseudomonasaeruginosaisolatedfromiraqihospitals
AT suhadsaadmahmoud firstdetectionofnewdelhimetalloblactamasesvariantsndm1ndm2amongpseudomonasaeruginosaisolatedfromiraqihospitals